Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event
TOKYO,Nov. 13, 2017 /PRNewswire/ -- Daiichi Sankyo Co., Ltd. (JP: 4568.T, OTC: DSNKY) based in Tokyo, Japan and focused on pharmaceutical business, today announced that Senior Director, IR group,
DATE: November 15th, 2017TIME: 11.30am ETLINK: www.adr.db.com/dbvic
This will be a live, interactive online event where investors are invited to ask international companies their questions in real-time and to download a company's information in their "virtual trade booth" in the Exhibits section. If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
Participation is free of charge.
It is recommended that investors pre-register to save time and receive event updates.
Recent Company Highlights
About Daiichi SankyoDaiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. For more information, please visit: www.daiichisankyo.com.
View original content:http://www.prnewswire.com/news-releases/daiichi-sankyo-to-present-at-the-dbvic---deutsche-bank-adr-virtual-investor-conference-on-november-15th-2017-300554435.html
SOURCE Daiichi Sankyo Co., Ltd.
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...View All